IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.87% | 12.77% | 13.08% | 10.42% | 8.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.87% | 12.77% | 13.08% | 10.42% | 8.39% |
| Cost of Revenue | 8.94% | 10.11% | 10.81% | 8.27% | 5.62% |
| Gross Profit | 13.69% | 14.43% | 14.52% | 11.80% | 10.18% |
| SG&A Expenses | 10.59% | 10.76% | 10.29% | 8.15% | 9.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.64% | 10.53% | 10.89% | 8.72% | 7.45% |
| Operating Income | 16.81% | 17.77% | 18.08% | 14.30% | 10.54% |
| Income Before Tax | 16.13% | 16.02% | 21.80% | 19.31% | 16.51% |
| Income Tax Expenses | 20.56% | 17.63% | 19.54% | 19.26% | 8.51% |
| Earnings from Continuing Operations | 15.06% | 15.62% | 22.38% | 19.33% | 18.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.06% | 15.62% | 22.38% | 19.33% | 18.61% |
| EBIT | 16.81% | 17.77% | 18.08% | 14.30% | 10.54% |
| EBITDA | 16.41% | 17.19% | 17.36% | 14.05% | 10.61% |
| EPS Basic | 17.33% | 18.22% | 25.40% | 22.39% | 21.44% |
| Normalized Basic EPS | 19.58% | 20.16% | 20.09% | 15.98% | 12.14% |
| EPS Diluted | 17.67% | 18.47% | 25.59% | 22.57% | 21.72% |
| Normalized Diluted EPS | 19.86% | 20.36% | 20.27% | 16.21% | 12.38% |
| Average Basic Shares Outstanding | -1.96% | -2.24% | -2.45% | -2.47% | -2.25% |
| Average Diluted Shares Outstanding | -2.19% | -2.40% | -2.60% | -2.67% | -2.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |